Modifications and insights into a method for the analysis of the nitrogen mustard mechlorethamine by high-performance

John C Reepmeyer1, Wei Ye, Wolfgang A Ritschel

  • 1United States Food and Drug Administration, Center for Drug Evaluation and Research, Office of Phamaceutical Science, Division of Pharmaceutical Analysis, FDA, 1114 Market Street, Room 1002, St. Louis, MO 63101, USA. john.reepmeyer@fda.hhs.gov

Related Concept Videos